| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/18/1996 | WO1996021416A2 Methods and compositions for treatment of solid tumors in vivo |
| 07/18/1996 | WO1996009399A3 Chimeric adenovirus for gene delivery |
| 07/18/1996 | WO1996009390A3 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 07/18/1996 | WO1996006860A3 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 07/18/1996 | WO1996003122A3 Use of gabapentin in the treatment of anxiety and panic |
| 07/18/1996 | WO1995034669A3 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 07/18/1996 | WO1995031981A3 Methods and compositions for reducing multidrug resistance |
| 07/18/1996 | DE4431945A1 Agent contg. interleukin=8 and/or its active fragments |
| 07/18/1996 | DE19501032A1 Agent for treating rheumatic diseases esp. arthritis |
| 07/18/1996 | DE19500990A1 Neues Peptid, seine Herstellung und Verwendung New peptide, its preparation and use |
| 07/18/1996 | CA2210390A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/18/1996 | CA2210318A1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen |
| 07/18/1996 | CA2210091A1 New applications of lysozyme dimer |
| 07/18/1996 | CA2210088A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases |
| 07/18/1996 | CA2209990A1 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | CA2209989A1 Compositions and methods for treating tumor cells |
| 07/18/1996 | CA2209941A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/18/1996 | CA2209557A1 Chemically modified interferon |
| 07/18/1996 | CA2209496A1 Novel peptides, their production and use |
| 07/18/1996 | CA2209492A1 Compositions for the delivery of antigens |
| 07/18/1996 | CA2207252A1 Inhibitors of prenyl transferases |
| 07/17/1996 | EP0721983A1 Methods of producing biologically active peptide dimers |
| 07/17/1996 | EP0721982A1 New staphylokinase derivatives |
| 07/17/1996 | EP0721957A1 Compound ge3 |
| 07/17/1996 | EP0721783A1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung and model animal for said diseases |
| 07/17/1996 | EP0721781A2 Reduction of adipose tissue using collagenase |
| 07/17/1996 | EP0721780A2 Agent for promoting platelet and/or leukocyte production |
| 07/17/1996 | EP0721776A1 Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 07/17/1996 | EP0721742A1 Nutrition for elderly patients |
| 07/17/1996 | EP0721586A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 07/17/1996 | EP0721510A1 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 07/17/1996 | EP0721506A1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/17/1996 | EP0721505A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/17/1996 | EP0721504A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
| 07/17/1996 | EP0721503A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE $g(b)/A4 AMYLOID-INDUCED MORPHOLOGY |
| 07/17/1996 | EP0721501A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 07/17/1996 | EP0721470A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/17/1996 | EP0721469A1 Anti-gp39 antibodies and uses therefor |
| 07/17/1996 | EP0721468A1 Novel peptide, active as inhibitors of platelet aggregation |
| 07/17/1996 | EP0721467A1 Use of relaxin as an analgesic and palliative for intractable pain |
| 07/17/1996 | EP0721466A1 Protective antigens against parasites |
| 07/17/1996 | EP0721465A1 Glutathione s-transferase-activated compounds |
| 07/17/1996 | EP0721464A1 Neuron regulatory factor for promoting neuron survival |
| 07/17/1996 | EP0721463A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 07/17/1996 | EP0721449A1 INHIBITORS OF $g(b)-AMYLOID PROTEIN PRODUCTION |
| 07/17/1996 | EP0721447A1 Anthracene derivatives for use as anticancer agent or dye |
| 07/17/1996 | EP0721352A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 07/17/1996 | EP0721351A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 07/17/1996 | EP0721350A1 Intracellular immunization |
| 07/17/1996 | EP0721347A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections |
| 07/17/1996 | EP0721346A1 Methods for inducing antigen-specific t cell tolerance |
| 07/17/1996 | EP0721344A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 07/17/1996 | EP0721343A1 Pharmaceutical formulations of nerve growth factor |
| 07/17/1996 | EP0721342A1 The semaphorin gene family |
| 07/17/1996 | EP0721341A1 Cloning and characterization of the complete mage-1 gene |
| 07/17/1996 | EP0721340A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 07/17/1996 | EP0721339A1 RECOMBINANT $g(a)-GALACTOSIDASE ENZYME AND cDNA ENCODING SAID ENZYME |
| 07/17/1996 | EP0681470B1 Recombinant living subunit vaccine composition and process for its preparation |
| 07/17/1996 | EP0638121B1 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence |
| 07/17/1996 | EP0601053A4 Compositions and methods for the sublingual or buccal administration of therapeutic agents. |
| 07/17/1996 | EP0593450B1 COMPOSITIONS comprising omega conotoxin peptide derivatives and their use FOR TREATING ISCHEMIA-RELATED NEURONAL DAMAGE |
| 07/17/1996 | EP0506868B1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 07/17/1996 | EP0496866B1 Hemoglobin-oligomer based composition and method to make same |
| 07/17/1996 | EP0441900B1 Natural killer stimulatory factor |
| 07/17/1996 | CN1127000A Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 07/17/1996 | CN1126999A Peptides exhibiting oxytocin antagonistic activity |
| 07/17/1996 | CN1126948A Methods and compositions for aiding periodontal tissue regeneration |
| 07/17/1996 | CN1126761A DNA sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 07/17/1996 | CN1126759A Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 07/17/1996 | CN1032308C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 07/16/1996 | US5536853 Opiate receptor ligands |
| 07/16/1996 | US5536814 Integrin-binding peptides |
| 07/16/1996 | US5536812 Calcitonin analogue and use thereof |
| 07/16/1996 | US5536750 Antitumor |
| 07/16/1996 | US5536716 Spiro piperidines and homologs which promote release of growth hormone |
| 07/16/1996 | US5536657 Recombinant DNA encoding human receptor for interleukin-12 |
| 07/16/1996 | US5536652 L-phenylalanyl-tRNA synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins |
| 07/16/1996 | US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
| 07/16/1996 | US5536508 Biodegradable polymer and polysaccharide gel and bioadhesive with drug |
| 07/16/1996 | US5536495 Proteins for organ rejection in tranplants |
| 07/16/1996 | CA2034489C Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 07/11/1996 | WO1996021028A2 Soluble heterodimeric t cell receptors and their antibodies |
| 07/11/1996 | WO1996021026A1 POLYMERASE δ MUTATIONS IN COLORECTAL TUMORS WITH REPLICATION ERRORS |
| 07/11/1996 | WO1996021025A1 Bovine factor xiii |
| 07/11/1996 | WO1996021021A2 A cancer associated gene, testis-associated helicase (tah), protein expressed therefrom and uses thereof |
| 07/11/1996 | WO1996021020A2 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | WO1996021016A2 New staphylokinase derivatives |
| 07/11/1996 | WO1996021015A2 Combination gene delivery vehicles |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996021013A1 Methods for diagnosis and treatment of mdk1 signal transduction disorders |
| 07/11/1996 | WO1996021011A2 PEPTIDES SPECIFIC FOR THE FIRST Crk-SH3 DOMAIN |
| 07/11/1996 | WO1996021006A1 Novel phosphoprotein secreted in the extracellular matrices of mammalian organs and methods for use thereof |
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020959A1 Novel monoclonal antibody having inhibitory effect on type ii phospholipase a2 and protein containing a part of the same |
| 07/11/1996 | WO1996020958A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | WO1996020957A1 Anti-inflammatory cd14 polypeptides |
| 07/11/1996 | WO1996020956A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | WO1996020955A1 Purified thrombopoietin and method of making it |
| 07/11/1996 | WO1996020954A2 Functionally active domains of signal transducer and activators of transcription (stat) proteins |
| 07/11/1996 | WO1996020950A2 Compositions and methods for treating rheumatoid arthritis |